New drugs against COVID-19 will significantly increase the survival chances of critically ill patients infected with the new coronavirus in 2022, World Health Organization (WHO) Regional Director for Europe Hans Kluge told TASS, Report informs.
“I am excited about the new antiviral drugs likely to hit the market in 2022, which will significantly increase survival chances for patients hospitalized with severe COVID-19,” he noted.
Kluge also emphasized that the next generation of vaccines will be more effective against new strains.
“I cannot predict the future. But the current vaccines are first-generation COVID-19 vaccines. Future vaccines will be advanced and adapted to new or emerging variants. This is similar to what is already happening with influenza vaccines, which adapt to new strains almost every year,” he explained.